Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Oct 9:7:706.
doi: 10.1186/1756-0500-7-706.

Lessons in participant retention in the course of a randomized controlled clinical trial

Olubukola T Idoko  1 , Olumuyiwa A Owolabi, Aderonke A Odutola, Olatunde Ogundare, Archibald Worwui, Yauba Saidu, Alison Smith-Sanneh, Abdoulie Tunkara, Gibbi Sey, Assan Sanyang, Philip Mendy, Martin O C Ota
Affiliations
Randomized Controlled Trial

Lessons in participant retention in the course of a randomized controlled clinical trial

Olubukola T Idoko et al. BMC Res Notes. .

Abstract

Background: Clinical trials are increasingly being conducted as new products seek to enter the market. Deployment of such interventions is based on evidence obtained mainly from the gold standard of randomized controlled clinical trials (RCCT). A crucial factor in the ability of RCCTs to provide credible and generalisable data is sample size and retention of the required number of subjects at completion of the follow-up period. However, recruitment and retention in clinical trials are hindered by prevalent peculiar challenges in Africa that need to be circumvented. This article shares experiences from a phase II trial that recorded a high retention rate at 14 months follow-up at a new clinical trial site.

Methods: Mothers bringing children less than two months of age to the health facility were given information and invited to have their child enrolled if the inclusion criteria were fulfilled. Participants were enrolled over 8 months. Trial procedures, duration and risks/benefits were painstakingly and sequentially explained to the communities, parents and relevant relatives before and during the trial period. The proportions of participants that completed or did not complete the trial were analyzed including the reasons for failure to complete all trial procedures.

Results: 1044 individuals received information regarding the trial of which 371 returned for screening. 300 (81%) of them who fulfilled the inclusion criteria and did not meet any exclusion criteria were enrolled and 94% of these completed the trial. Consent withdrawal was the main reason for not completing the trial largely (75%) due to the father not being involved at the point of consenting or parents no longer being comfortable with blood sampling.

Conclusions: Participant retention in clinical trials remains a crucial factor in ensuring generalisability of trial data. Appropriate measures to enhance retention should include continuous community involvement in the process, adequate explanation of trial procedures and risks/benefits; and innovative tracing of participants adapted for the setting.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Methods utilized.
Figure 2
Figure 2
Participant flow during the trial.
Figure 3
Figure 3
Enrolment/Drop out rate.
See this image and copyright information in PMC

References

    1. Davis LL, Broome ME, Cox RP. Maximizing retention in community-based clinical trials. J Nurs Scholarsh. 2002;34:47–53. doi: 10.1111/j.1547-5069.2002.00047.x. - DOI - PubMed
    1. Mor M, Niv G, Niv Y. Patient retention in a clinical trial: a lesson from the rofecoxib (VIOXX) study. Dig Dis Sci. 2006;51:1175–1178. doi: 10.1007/s10620-006-8028-5. - DOI - PubMed
    1. Ota MO, Idoko OT, Ogundare EO, Afolabi MO. Human immune responses to vaccines in the first year of life: biological, socio-economic and ethical issues - a viewpoint. Vaccine. 2013;31:2483–2488. doi: 10.1016/j.vaccine.2012.06.018. - DOI - PubMed
    1. Morse EV, Simon PM, Besch CL, Walker J. Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations. Appl Nurs Res. 1995;8:8–14. doi: 10.1016/S0897-1897(95)80240-1. - DOI - PubMed
    1. Hill PD, Humenick SS. Comparison of subjects who fully versus minimally participated in a breast-feeding study. West J Nurs Res. 1995;17:328–334. doi: 10.1177/019394599501700308. - DOI - PubMed

Publication types

LinkOut - more resources